您的位置：首页 > 产品中心 > 321883-54-9， 08:0 PA
08:0 PA
| 产品编号： | 4095455 |
| 规格： | 1,2-dioctanoyl-sn-glycero-3-phosphate (sodium salt), powder |
| CAS NO： | 321883-54-9 |
| 包装规格： | 10 MG |
| 产品类别： | 进口试剂 |
| 品牌： | Avanti |
| 优惠价： | 立即咨询 |
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 4095455 | 10 MG | 2680 |
产品别名
321883-54-9
08:0 PA
PA(8:0/8:0)
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C19H36O8PNa |
| Molecular weight | 446.45 |
| NACRES | NA.25 |
| General description【一般描述】 | Phosphatidic acid is obtained from glycerophospholipid with the help of phospholipase D. 08:0 PA/1,2-dioctanoyl-sn-glycero-3-phosphate (C8-PA) is an mammalian target of rapamycin (mTOR) activator. |
| Application【应用】 | 08:0 PA may be used to activate p-mTOR in order to assess whether the observed apoptotic effect of histone deacetylase inhibitors (HDACIs) is related to mammalian target of rapamycin (mTOR) pathway signaling. |
| Biochem/physiol Actions【生化/生理作用】 | Phosphatidic acid might serve as a modulator of phagocyte respiratory burst. It also acts as a precursor of diacylglycerol and lysophosphatidic acid. 08:0 PA/C8-PA has the ability to affect the phosphorylation of mammalian target of rapamycin (mTOR) and the viability of gallbladder carcinoma cells, that are treated with histone deacetylase inhibitors (HDACIs). |
产品性质
| Assay【测定】 | >99% (TLC) |
| form【形式】 | powder |
| manufacturer/tradename | Avanti Polar Lipids 830842P |
| shipped in【运输】 | dry ice |
| storage temp.【储存温度】 | −20℃ |
| SMILES string | [H][C@@](COP([O-])(O)=O)(OC(CCCCCCC)=O)COC(CCCCCCC)=O.[Na+] |
| packaging【包装】 | 5 mL Clear Glass Sealed Ampule (830842P-10mg) 5 mL Clear Glass Sealed Ampule (830842P-25mg) |
安全信息
| Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
